Phase
Condition
Gastroesophageal Reflux Disease (Gerd)
Esophageal Disorders
Heartburn (Pediatric)
Treatment
Tegoprazan
Pantoprazole
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
With endoscopic diagnosis of GERD or NERD (endoscopy ≤ 15 days old)
With positive impedance pHmetry results (pHmetry ≤ 15 days old)
With recurrent symptoms of heartburn and regurgitation for a previous period ≥ 3months old
Exclusion
Exclusion Criteria:
With known hypersensitivity to tegoprazan, pantoprazole, or any of the components ofeach formulation
Subjects with concomitant administration of atazanavir, nelfinavir or rilpivirine
Nephropathic and/or hepatopathic subjects (including non-alcoholic hepatitis)
Subjects with upper gastrointestinal tract bleeding
Subjects with gastric and/or duodenal ulcer 2 months prior to screening
Subjects with a history of esophageal or gastric surgery
Study Design
Connect with a study center
Gastrologen S.A. de C.V.
Mexico, Ciudad de México 01900
MexicoActive - Recruiting
Saluz Investigación, S.C.
Boca del Río, Veracruz 94299
MexicoActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.